La derecha en EE. UU. sigue defendiendo a la ivermectinanews2025-04-01T14:33:37+00:00April 1st, 2025|The New York Times|
Why the Right Still Embraces Ivermectinnews2025-03-31T15:01:02+00:00March 31st, 2025|The New York Times|
R.F.K. Jr. Wants to Overhaul the F.D.A. How Would Scientists Change It?news2024-12-22T10:00:41+00:00December 22nd, 2024|The New York Times|
From AI to Musk’s Brain Chip, the F.D.A.’s Device Unit Faces Rapid Changenews2024-11-01T23:57:56+00:00November 1st, 2024|The New York Times|
Drug Shortages Near an All-Time High, Leading to Rationingnews2023-05-17T13:31:02+00:00May 17th, 2023|The New York Times|
F.D.A. Seeks Outside Review of Troubled Food and Tobacco Unitsnews2022-07-21T03:41:53+00:00July 21st, 2022|The New York Times|
F.D.A. to Weigh Over-the-Counter Sale of Birth Control Pillsnews2022-07-11T22:47:25+00:00July 11th, 2022|The New York Times|
Senate Confirms Califf as F.D.A. Chief in Tight Votenews2022-02-15T18:47:59+00:00February 15th, 2022|The New York Times|
F.D.A. Nominee Faces Steep Climb to Senate Confirmationnews2022-02-03T17:31:17+00:00February 3rd, 2022|The New York Times|
